Update date
31 Mar 2021
Shareable Research Card
ADMA - ADMA BIOLOGICS, INC. Operating Margin
This metric view shows ADMA - ADMA BIOLOGICS, INC. operating margin history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q1 2021
- Latest reported value
- -132%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Mar 2021
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q1 2021.
- Latest reported value on this page: -132%.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Operating Margin
Latest reported operating margin: -132%. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q1 2021
SEC-backed company facts were refreshed from filings filed on 15 Apr 2026.
Benchmark Context
How Operating Margin compares with peers
ADMA BIOLOGICS, INC. is outside the visible top 120 companies for operating margin in the current sample.
Compared with
Compared with 120 companies reporting operating margin in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about -0.7x the current sample midpoint. Operating Margin is down about 5.5% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2011 to 31 Dec 2025.
- Nearby companies in this sample: Global Warming Solutions, Inc. and NAMI Corp..
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
ADMA BIOLOGICS, INC.: Operating Margin
Latest period: Q1 2021. Period end: 31 Mar 2021. Units: %. Frequency: quarterly and annual.
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Metric Snapshot
- Latest value
- -132%
- Coverage range
- 31 Dec 2011 - 31 Mar 2021
- Fact rows
- 47
What This Metric Tells You
- Shows the reported level of operating margin over 31 Dec 2011 - 31 Mar 2021.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 47 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Global Warming Solutions, Inc. (gwso) | 99905400% | Quarter - 30 Sep 2022 | Open Global Warming Solutions, Inc. Operating Margin |
| 2 | NAMI Corp. | 1080289% | Quarter - 31 Mar 2021 | Open NAMI Corp. Operating Margin |
| 3 | PharmaCyte Biotech, Inc. (pmcb) | 396584% | Quarter - 31 Jan 2014 | Open PharmaCyte Biotech, Inc. Operating Margin |
| 4 | ALR Technologies SG Ltd. (alrtf) | 180380% | Year - 31 Dec 2022 | Open ALR Technologies SG Ltd. Operating Margin |
| 5 | MUSTANG BIO, INC. (mbio) | 83624% | Quarter - 30 Sep 2019 | Open MUSTANG BIO, INC. Operating Margin |
| 6 | DOMINION ENERGY SOUTH CAROLINA, INC. | 63100% | Quarter - 31 Dec 2020 | Open DOMINION ENERGY SOUTH CAROLINA, INC. Operating Margin |
Metric Details
- Metric
- Operating Margin (OperatingMargin)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 31 Dec 2011 - 31 Mar 2021
- Facts on this page
- 47
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
ADMA BIOLOGICS, INC. Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q1 2021 | -132% | -6.8% | -5.5% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -154% | -13% | -8.9% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | -138% | +97% | +41% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | -136% | +162% | +54% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | -125% | +221% | +64% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | -141% | +214% | +60% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | -235% | -17% | -7.8% | 01 Jul 2019 | 30 Sep 2019 |
| Q2 2019 | -299% | -83% | -38% | 01 Apr 2019 | 30 Jun 2019 |
| Q1 2019 | -346% | -139% | -68% | 01 Jan 2019 | 31 Mar 2019 |
| Q4 2018 | -355% | -182% | -106% | 01 Oct 2018 | 31 Dec 2018 |
| Q3 2018 | -218% | +14% | +6.2% | 01 Jul 2018 | 30 Sep 2018 |
| Q2 2018 | -216% | -37% | -21% | 01 Apr 2018 | 30 Jun 2018 |
| Q1 2018 | -206% | -35% | -21% | 01 Jan 2018 | 31 Mar 2018 |
| Q4 2017 | -173% | -10% | -6.2% | 01 Oct 2017 | 31 Dec 2017 |
| Q3 2017 | -232% | -54% | -31% | 01 Jul 2017 | 30 Sep 2017 |
| Q2 2017 | -179% | +31% | +15% | 01 Apr 2017 | 30 Jun 2017 |
| Q1 2017 | -171% | +40% | +19% | 01 Jan 2017 | 31 Mar 2017 |
| Q4 2016 | -163% | +54% | +25% | 01 Oct 2016 | 31 Dec 2016 |
| Q3 2016 | -178% | +67% | +27% | 01 Jul 2016 | 30 Sep 2016 |
| Q2 2016 | -211% | +27% | +11% | 01 Apr 2016 | 30 Jun 2016 |
| Q1 2016 | -211% | +20% | +8.6% | 01 Jan 2016 | 31 Mar 2016 |
| Q4 2015 | -216% | +55% | +20% | 01 Oct 2015 | 31 Dec 2015 |
| Q3 2015 | -245% | +102% | +29% | 01 Jul 2015 | 30 Sep 2015 |
| Q2 2015 | -238% | +118% | +33% | 01 Apr 2015 | 30 Jun 2015 |
| Q1 2015 | -231% | +227% | +50% | 01 Jan 2015 | 31 Mar 2015 |
| Q4 2014 | -271% | +220% | +45% | 01 Oct 2014 | 31 Dec 2014 |
| Q3 2014 | -347% | +56% | +14% | 01 Jul 2014 | 30 Sep 2014 |
| Q2 2014 | -355% | +202% | +36% | 01 Apr 2014 | 30 Jun 2014 |
| Q1 2014 | -458% | +58% | +11% | 01 Jan 2014 | 31 Mar 2014 |
| Q4 2013 | -490% | +217% | +31% | 01 Oct 2013 | 31 Dec 2013 |
| Q3 2013 | -403% | +1204% | +75% | 01 Jul 2013 | 30 Sep 2013 |
| Q2 2013 | -557% | +881% | +61% | 01 Apr 2013 | 30 Jun 2013 |
| Q1 2013 | -516% | +96093% | +99% | 01 Jan 2013 | 31 Mar 2013 |
| Q4 2012 | -707% | 01 Oct 2012 | 31 Dec 2012 | ||
| Q3 2012 | -1607% | 01 Jul 2012 | 30 Sep 2012 | ||
| Q2 2012 | -1438% | 01 Apr 2012 | 30 Jun 2012 | ||
| Q1 2012 | -96609% | 01 Jan 2012 | 31 Mar 2012 |
ADMA BIOLOGICS, INC. Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2020 | -154% | -13% | -8.9% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -141% | +214% | +60% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | -355% | -182% | -106% | 01 Jan 2018 | 31 Dec 2018 |
| 2017 | -173% | -10% | -6.2% | 01 Jan 2017 | 31 Dec 2017 |
| 2016 | -163% | +54% | +25% | 01 Jan 2016 | 31 Dec 2016 |
| 2015 | -216% | +55% | +20% | 01 Jan 2015 | 31 Dec 2015 |
| 2014 | -271% | +220% | +45% | 01 Jan 2014 | 31 Dec 2014 |
| 2013 | -490% | +217% | +31% | 01 Jan 2013 | 31 Dec 2013 |
| 2012 | -707% | -100% | -16% | 01 Jan 2012 | 31 Dec 2012 |
| 2011 | -607% | 01 Jan 2011 | 31 Dec 2011 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.